RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Pregnancy in the Setting of the SARS-CoV-2 Pandemic

by dtrubin | March 26, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, A lot of concern has recently come up regarding pregnancy in the setting of the SARS-CoV-2 pandemic. Here are some key points I found on this issue: Pregnancy is a state of...

Dr. David T. Rubin Reflects on How to Avoid the Next Pandemic with WGN’s Steve Dale

by David Rubin | January 18, 2022 | In the Press | 0 Comments

Click here to listen to the full interview.

Three waves of Illness from the COVID-19 Pandemic

by dtrubin | April 1, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

“Monitor Histologically Normalized UC for Relapse” on MedPage Today

by dtrubin | June 27, 2019 | histology, In the Press, normalization, UC | 0 Comments

"These patients require ongoing monitoring and follow-up," the study's first author, Amanda M. Israel, MD, also of the University of Chicago Medicine, told MedPage Today. Our graduating Advanced IBD Fellow, Amanda Israel, was published her findings on the “Follow-Up...

Definition of “healing” and sustained remission

by dtrubin | December 6, 2019 | histology, normalization, Rubin's Reflections | 0 Comments

The FDA and others have been interested in the role of histology for assessing “deeper” levels of disease control, with the premise that biopsy may reflect the state of the disease more accurately and perhaps more objectively than endoscopy, and certainly more than...

IBD Drive Time: Dr. David Rubin, MD, on Ozanimod in Ulcerative Colitis

by David Rubin | August 6, 2021 | In the Press | 0 Comments

Click here to listen to Dr. Rubin speak with colleagues and IBD Drive Time hosts Raymond Cross, MD and Millie Long, MD on using newly-approved ozanimod in treating ulcerative colitis.

Dr. Noa Krugliak Cleveland Discusses Her Award-Winning Research on Decreasing Time to Treatment Change and Remission in IBD Patients

by David Rubin | October 25, 2023 | In the Press | 0 Comments

At this year's ACG (American College of Gastroenterology) Conference in Vancouver, British Columbia, Canada, Dr. Noa Krugliak Cleveland gave an oral presentation on her award-winning abstract "Monitoring IBD by Intestinal Ultrasound Decreases Time to Treatment Change...

Improvements in Testing for SARS-CoV-2 and COVID-19 and How They Will Transform What we are Doing

by dtrubin | April 1, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Here are some improvements in testing for SARS-COV-2 and COVID-19 and how I think they will transform what we are doing: 1. Faster Viral Tests for SARS-CoV-2. Several companies have adapted...

Dr. David Rubin receives the Bruce and Cynthia Sherman Charitable Foundation’s 2020 Sherman Prize

by David Rubin | October 29, 2020 | In the Press | 0 Comments

Dr. Rubin was recently announced as one of three recipients of the 2020 Sherman Prize. Sherman Prize recipients "are outstanding individuals who consider the whole patient experience — not just the serious symptoms, but also the psychological and practical components...

IBD Drive Time Podcast: Ethical Issues in Clinical Trials

by David Rubin | October 19, 2023 | In the Press | 0 Comments

Take a listen to the third episode of a four-part series wherein Professor Rubin guest-hosts the Gastroenterology Learning Network's IBD Drive Time and discusses the ethics of clinical trials in IBD, as well as challenges to recruitment, alongside Professor Severine...